Dramatic decline of serogroup C meningococcal disease in Catalonia (Spain) after a mass vaccination campaign with meningococcal C conjugated vaccine

By Salleras L.   Domnguez A.   Cardenosa N.  

Vaccine, Vol. 21, Iss. 7, 2003-01 ,pp. : 729-733

Elsevier

Access to resources Recommend Favorite

Impact of mass vaccination with polysaccharide conjugate vaccine against serogroup C meningococcal disease in Spain

By Salleras L.   Domnguez A.   Cardenosa N.  

Vaccine, Vol. 21, Iss. 7, 2003-01 ,pp. : 725-728

Elsevier

Access to resources Recommend Favorite

Neisseria meningitidis serogroup B outer membrane vesicle vaccine in adults with occupational risk for meningococcal disease

By Fischer M.   Carlone G.M.   Holst J.   Williams D.   Stephens D.S.   Perkins B.A.  

Vaccine, Vol. 17, Iss. 19, 1999-05 ,pp. : 2377-2383

Elsevier

Access to resources Recommend Favorite

Surveillance for meningococcal disease and strategies for use of conjugate meningococcal vaccines in the United States

By Lingappa J.R.   Rosenstein N.   Zell E.R.   Shutt K.A.   Schuchat A.   Perkins B.A.   Active Bacterial Core Surveillance ABCs Team  

Vaccine, Vol. 19, Iss. 31, 2001-08 ,pp. : 4566-4575

Elsevier

Access to resources Recommend Favorite

Reduced antibody response to revaccination with meningococcal serogroup A polysaccharide vaccine in adults

By Borrow R.   Joseph H.   Andrews N.   Acuna M.   Longworth E.   Martin S.   Peake N.   Rahim R.   Richmond P.   Kaczmarski E.   Miller E.  

Vaccine, Vol. 19, Iss. 9, 2000-12 ,pp. : 1129-1132

Elsevier

Access to resources Recommend Favorite